Literature DB >> 15747752

Aggressive retinal astrocytomas in four patients with tuberous sclerosis complex.

Jerry A Shields1, Ralph C Eagle, Carol L Shields, Brian P Marr.   

Abstract

OBJECTIVE: To report the clinical and histopathologic findings of retinal astrocytic tumors that showed progressive growth in four patients with tuberous sclerosis complex (TSC).
METHODS: Four young children each developed an enlarging retinal neoplasm that eventually necessitated enucleation of the affected eye. The systemic findings, clinical course, and histopathologic findings were reviewed.
RESULTS: Each patient had a progressively enlarging retinal mass associated with a total exudative retinal detachment and neovascular glaucoma. Enucleation was necessary in each case because the affected eye became blind and painful. The mean patient age at enucleation was 7 years, and the median age was 3 years. At the time of enucleation the tumors ranged from 10 to 20 mm in basal diameter and from 10 to 25 mm in thickness. Histopathologic studies of each eye revealed a giant cell astrocytoma that had produced a total exudative retinal detachment. The tumor cells showed positive immunoreactivity to neuron-specific enolase and glial fibrillary acidic protein. The retinal neoplasms in these cases were identical histopathologically to the subependymal giant cell astrocytoma that typifies TSC in the brain. One tumor filled the entire eye and perforated the globe. Although the lesions simulated retinoblastoma clinically, each patient had ocular and systemic findings of TSC, supporting the diagnosis of astrocytic hamartoma.
CONCLUSIONS: Although retinal astrocytic lesions of TSC generally are stationary, they can sometimes grow relentlessly and cause severe ocular complications. Patients with retinal astrocytic hamartomas should have serial ophthalmic evaluations because of this possibility.

Entities:  

Mesh:

Year:  2004        PMID: 15747752      PMCID: PMC1280094     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  29 in total

1.  RETINAL GLIONEUROMA ASSOCIATED WITH TUBEROUS SCLEROSIS.

Authors:  L K GARRON; W H SPENCER
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1964 Nov-Dec

2.  Ophthalmic manifestations of tuberous sclerosis.

Authors:  D M Robertson
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

3.  Solitary retinal astrocytoma.

Authors:  A C Arnold; R S Hepler; R W Yee; J Maggiano; L F Eng; R Y Foos
Journal:  Surv Ophthalmol       Date:  1985 Nov-Dec       Impact factor: 6.048

4.  Invasive giant cell astrocytoma of the retina in a patient with tuberous sclerosis.

Authors:  K Gündüz; R C Eagle; C L Shields; J A Shields; J J Augsburger
Journal:  Ophthalmology       Date:  1999-03       Impact factor: 12.079

5.  Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture.

Authors:  J A Shields; C L Shields; S G Honavar; H Demirci
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

6.  Giant cell astrocytoma of the retina in tuberous sclerosis.

Authors:  C E Margo; J P Barletta; J A Staman
Journal:  Retina       Date:  1993       Impact factor: 4.256

Review 7.  Tuberous sclerosis.

Authors:  D J Kwiatkowski; M P Short
Journal:  Arch Dermatol       Date:  1994-03

Review 8.  Progressive enlargement of acquired retinal astrocytoma in 2 cases.

Authors:  Carol L Shields; Jerry A Shields; Ralph C Eagle; Francis Cangemi
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

9.  The molecular genetics of tuberous sclerosis.

Authors:  J R Sampson; P C Harris
Journal:  Hum Mol Genet       Date:  1994       Impact factor: 6.150

10.  Astrocytic hamartoma of the retina not associated with tuberous sclerosis.

Authors:  F H Reeser; T M Aaberg; D L Van Horn
Journal:  Am J Ophthalmol       Date:  1978-11       Impact factor: 5.258

View more
  14 in total

1.  CT of sclerotic bone lesions: imaging features differentiating tuberous sclerosis complex with lymphangioleiomyomatosis from sporadic lymphangioleiomymatosis.

Authors:  Nilo A Avila; Andrew J Dwyer; Antoinette Rabel; Thomas Darling; Chien-Hui Hong; Joel Moss
Journal:  Radiology       Date:  2010-03       Impact factor: 11.105

Review 2.  Congenital focal abnormalities of the retina and retinal pigment epithelium.

Authors:  Yingna Liu; Anthony T Moore
Journal:  Eye (Lond)       Date:  2020-05-04       Impact factor: 3.775

3.  Reactive retinal astrocytic tumors (so-called vasoproliferative tumors): histopathologic, immunohistochemical, and genetic studies of four cases.

Authors:  Lynn J Poole Perry; Frederick A Jakobiec; Fouad R Zakka; Elias Reichel; Martina C Herwig; Arie Perry; Daniel J Brat; Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2012-12-06       Impact factor: 5.258

4.  Optical coherence tomography of retinal astrocytic hamartomas in a 4-year-old boy affected by tuberous sclerosis.

Authors:  Giovanni Spinucci; Lucia Restivo; Maria Pia Paroli; Maurizio La Cava
Journal:  Int Ophthalmol       Date:  2013-01-26       Impact factor: 2.031

5.  Tuberous sclerosis complex: a clinical case with multiple ophthalmological manifestations.

Authors:  Tiago Maio; José Lemos; Jorge Moreira; Filipa Sampaio
Journal:  BMJ Case Rep       Date:  2018-10-25

6.  Macular telangiectasia type 2 accompanied by solitary retinal astrocytic hamartoma (case report).

Authors:  Martin Pencak; Jan Krasny; Miroslav Veith; Magdalena Vokrojova
Journal:  BMC Ophthalmol       Date:  2016-11-11       Impact factor: 2.209

7.  Chronic papilledema in a child with classical tuberous sclerosis.

Authors:  Khyati Amit Jain; Amit Bhurmal Jain
Journal:  Indian J Ophthalmol       Date:  2018-01       Impact factor: 1.848

8.  Optic nerve head reactive retinal astrocytic tumor treated with photodynamic therapy.

Authors:  Alex C Onishi; Lee M Jampol; Amani A Fawzi
Journal:  Am J Ophthalmol Case Rep       Date:  2020-07-10

9.  Neuro-ophthalmological manifestations of tuberous sclerosis: current perspectives.

Authors:  Michael J Wan; Ka Lo Chan; Benjamin G Jastrzembski; Asim Ali
Journal:  Eye Brain       Date:  2019-06-19

10.  A novel mouse model of tuberous sclerosis complex (TSC): eye-specific Tsc1-ablation disrupts visual-pathway development.

Authors:  Iwan Jones; Anna-Carin Hägglund; Gunilla Törnqvist; Christoffer Nord; Ulf Ahlgren; Leif Carlsson
Journal:  Dis Model Mech       Date:  2015-10-08       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.